...which is all that really matters for this company.
My understanding is that the elderly Phase 3 would actually be quite a bit smaller(200) than the Phase 2 number.
..so well said. Unfortunately I learned a hard lesson investing in a highly speculative Biotech with a bogus management team with zero credible background or experience.
....big deal. One would hope that with good Phase 2 data the price targets start to rise significantly.
....just a question for the Board. IMHO, if RSV Phase 2 trials are successful, we get to the $20's in 2016. A buyout could be well north of $30 if it were to occur. How does Pharma not approach NVAX with offers if NVAX cracks the RSV virus?
...no responses on this one? Kind of more germane to the whole thesis of owning NVAX than wasting time posting about MERS.
...endless pie in the sky pumping for years of a stock that has badly hurt all its investors. Macaluso & Clift have proven that they are incapable of designing and conducting a 2nd successful Phase 3 trial. They are in over their head. I stuck by them for 3 years, and learned a hard lesson by investing in this grossly inexperienced management team.
...why they suck so much? Why they are grossly inept? Why they are unable to conduct a successful Phase 3 trial? The bashers were right all along regarding (mis)management. Hard lesson learned.
And if anyone thinks the FDA is going to allow them to file a BLA without another Phase 3, they are delusional. They will be out of money next year.
The only surprise is how truly incompetent management has turned out to be. EVERYTHING they said would happen hasn't.
The shorts had this pegged from the beginning. You continue to look like a fool.
...that they have never once delivered on anything that they have promised? 2 failed trials veiled by meager data releases. Does anyone trust them to successfully conduct a 3rd Phase 3 trial?? A management team that is grossly inexperienced.
The end game is eventual bankruptcy.
..so sad that you are still pumping....will you still be here when it is at $1.00?
...that is the question.
....they've stated more than once that they feel they've made a breakthrough with RSV, and the Ebola & Quad Flu results leads one to believe that they will nail RSV also.
I don't think they hold a call without results from one of the 2 RSV trials in - they have until the end of August to have the CC